Gender Related Differences in Gastrointestinal Bleeding With Oral Anticoagulation in Atrial Fibrillation

Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge

(2021) Jakub Z. Qazi et al.   PLoS One

Comparing Major Bleeding Risk in Outpatients with Atrial Fibrillation or Flutter by Oral Anticoagulant Type (From the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence Registry)

(2020) Jonathan M. Wong et al.   AMERICAN JOURNAL OF CARDIOLOGY

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation

(2020) Celina M. Yong et al.   Journal of the American Heart Association

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

(2020) Gerhard Hindricks et al.   EUROPEAN HEART JOURNAL

Real-world persistence with direct oral anticoagulants (DOACs) in naïve patients with non-valvular atrial fibrillation

(2019) Eliana Ferroni et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

DOACS in women: pros and cons

(2019) Jan Beyer-Westendorf   THROMBOSIS RESEARCH

Gender Differences in Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Network Meta-analysis

(2018) Bruria Hirsh Raccah et al.   ANNALS OF PHARMACOTHERAPY

Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation

(2018) Sharon W.Y. Law et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago

(2017) Gualtiero Palareti et al.   Internal and Emergency Medicine

Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study

(2017) Gentian Denas et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences

(2017) Marco Proietti et al.   PHARMACOLOGICAL RESEARCH

Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores

(2017) Vanessa Roldán et al.   THROMBOSIS AND HAEMOSTASIS

Atrial fibrillation in women: treatment

(2016) Darae Ko et al.   Nature Reviews Cardiology

Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin

(2016) Keitaro Senoo et al.   STROKE

Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC: Figure 1

(2015) Giuseppe M.C. Rosano et al.   EUROPEAN HEART JOURNAL

Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes

(2015)   EUROPEAN HEART JOURNAL

Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation

(2015) Alberto Tosetto et al.   PLoS One

Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta-analysis

(2014) S. Takach Lapner et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Ensuring medication adherence with direct oral anticoagulant drugs

(2014) Alessandro Di Minno et al.   THROMBOSIS RESEARCH

Atrial Fibrillation, Stroke, and Anticoagulation in Medicare Beneficiaries: Trends by Age, Sex, and Race, 1992–2010

(2014) Gautam R. Shroff et al.   Journal of the American Heart Association

Meta-Analysis of Gender Differences in Residual Stroke Risk and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants

(2013) Samir B. Pancholy et al.   AMERICAN JOURNAL OF CARDIOLOGY

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

(2013) Stavros Apostolakis et al.   CHEST

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Venous Thromboembolism in an Industrial North American City: Temporal Distribution and Association with Particulate Matter Air Pollution

(2013) Holly H. Chiu et al.   PLoS One

Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007

(2012) Jonathan P. Piccini et al.  

Sex/Gender Differences in Cardiovascular Disease Prevention

(2011) Lori Mosca et al.   CIRCULATION

An automated database case definition for serious bleeding related to oral anticoagulant use

(2011) Andrew Cunningham et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention

(2010) Chiara Melloni et al.  

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment

(2009) Emilia Antonucci et al.   THROMBOSIS AND HAEMOSTASIS